Tempest Therapeutics

Tempest Therapeutics

Development-stage biotechnology company.

HQ location
San Francisco, United States
Launch date
Employees
Market cap
$25.4m
Enterprise value
$17m
Share price
$6.80 TPST
Authorizing premium user...